U.S. Senate panel urges FTC to launch antitrust probe of Mylan
WASHINGTON (Reuters) - The U.S. Senate Judiciary Committee urged federal antitrust regulators on Monday to launch a probe into whether EpiPen maker Mylan NV broke the law by preventing schools from purchasing competing allergy treatments.
No comments:
Post a Comment